<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00071032</url>
  </required_header>
  <id_info>
    <org_study_id>159</org_study_id>
    <secondary_id>U01HL073958-06</secondary_id>
    <secondary_id>U01HL073958</secondary_id>
    <secondary_id>U01HL074815</secondary_id>
    <nct_id>NCT00071032</nct_id>
  </id_info>
  <brief_title>Safety and Effectiveness of Two Blood Transfusion Strategies in Surgical Patients With Cardiovascular Disease</brief_title>
  <acronym>FOCUS</acronym>
  <official_title>Functional Outcomes in Cardiovascular Patients Undergoing Surgical Hip Fracture Repair (FOCUS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rutgers, The State University of New Jersey</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Rutgers, The State University of New Jersey</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare liberal red blood cell transfusion therapy with&#xD;
      restrictive red blood cell transfusion therapy in surgical patients with cardiovascular&#xD;
      disease or risk factors.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      BACKGROUND:&#xD;
&#xD;
      Red blood cell transfusions are an extremely common medical intervention in both the United&#xD;
      States and worldwide; over 14 million units of blood are transfused in the United States.&#xD;
      Between 60 and 70 percent of all blood is transfused in the surgical setting. Despite the&#xD;
      common use of red blood cell transfusions, the threshold for transfusion has not been&#xD;
      adequately evaluated and is very controversial. A decade ago, the standard of care was to&#xD;
      administer a peri-operative transfusion whenever the hemoglobin (Hgb) level fell below 10&#xD;
      g/dl (the &quot;10/30 rule&quot;). Concerns about the safety of blood, especially with respect to HIV&#xD;
      and hepatitis, and the absence of data to support a 10 g/dl threshold led to the current&#xD;
      standard of care, which is to administer blood transfusions based on the presence of&#xD;
      symptoms, and not a specific Hgb/hematocrit level. However, there have not been any&#xD;
      randomized clinical trials done with surgical patients that have tested the efficacy and&#xD;
      safety of withholding blood until the patient develops symptoms, or the &quot;10/30&quot; approach to&#xD;
      transfusion. Patients with underlying cardiovascular disease are at greatest risk of adverse&#xD;
      effects from reduced Hgb levels.&#xD;
&#xD;
      DESIGN NARRATIVE:&#xD;
&#xD;
      This is a multi-center randomized trial to test the effectiveness of a transfusion strategy&#xD;
      that maintains postoperative Hgb levels above 10 g/dl (liberal transfusion) in improving&#xD;
      patient outcome. This will be compared to the restrictive (symptomatic) transfusion strategy&#xD;
      in which blood transfusion is withheld until the patient develops symptoms of anemia or Hgb&#xD;
      less than 8 g/dL. Participants will be randomly assigned to one of the two transfusion&#xD;
      strategies. The liberal (10 g/dl) threshold strategy will use enough red blood cell units to&#xD;
      maintain Hgb levels at or above 10 g/dl through hospital discharge. Restrictive (Symptomatic)&#xD;
      transfusion strategy patients will receive red blood cell transfusions for symptoms of&#xD;
      anemia, although transfusion is also permitted, but not required, if the Hgb level falls&#xD;
      below 8 g/dl. Outcomes will include functional recovery (primary outcome: ability to walk 10&#xD;
      feet across a room without human assistance or death 60 days post-randomization), lower&#xD;
      extremity activities of daily living and instrumental activities of daily living, survival up&#xD;
      to 60-days and long-term, disposition (i.e., nursing home placement), and postoperative&#xD;
      complications (e.g., myocardial infarction, unstable angina, or death in hospital, pneumonia,&#xD;
      wound infection, thromboembolism, stroke).&#xD;
&#xD;
      Ambulation at 60 days is known to be highly predictive of ultimate functional outcome as well&#xD;
      as of mortality at one year. Because inability to walk has such important implications for&#xD;
      quality of life, and because it is a common problem, it far outweighs the small risk of viral&#xD;
      infection or other complications from transfusion in elderly patients.&#xD;
&#xD;
      The trial will also evaluate the effect of transfusion threshold on postoperative risk of&#xD;
      acute cardiac ischemia. The strategy will be to enhance surveillance for ischemic events by&#xD;
      increasing the number of EKG and serum troponin measurements beyond those already called for&#xD;
      in the original FOCUS protocol.&#xD;
&#xD;
      There is an ancillary study to the trial (R01 HL085706) to examine delirium as an outcome in&#xD;
      a subsample of 139 patients. We will assess short-term (in hospital) and longer-term (after&#xD;
      30 days) severity of delirium.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2003</start_date>
  <completion_date type="Actual">May 2009</completion_date>
  <primary_completion_date type="Actual">May 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Inability to Walk 10 Feet or Across a Room Without Human Assistance or Death</measure>
    <time_frame>60 days after randomization</time_frame>
    <description>ascertained via telephone follow-up</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Myocardial Infarction, Unstable Angina, or Death for Any Reason</measure>
    <time_frame>In-hospital</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality at 30 Days</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality at 60 Days</measure>
    <time_frame>60 Days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite Outcomes (a) Death, Myocardial Infarction, or Pneumonia and b) Death, Myocardial Infarction, Pneumonia, Thromboembolism, or Stroke</measure>
    <time_frame>In-hospital</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial Infarction</measure>
    <time_frame>In-hospital</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Complications (e.g., Wound Infection, Thromboembolism, Stroke)</measure>
    <time_frame>In hospital</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disposition Status (i.e., Nursing Home Placement)</measure>
    <time_frame>60 days</time_frame>
    <description>Nursing Home Residence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Function - Lower Extremity Activities of Daily Living,at 30 Days</measure>
    <time_frame>30 days</time_frame>
    <description>Using the Functional Status Index, score range 0 to 11, higher scores indicate greater dependency</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Function - Instrumental Activities of Daily Living, at 30 Days</measure>
    <time_frame>30 days</time_frame>
    <description>Using the Older Americans Resources and Services Functional Assessment Questionnaire, score range from 0 to 4, higher scores indicating greater dependency</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Function - Fatigue/Energy, at 30 Days</measure>
    <time_frame>30 days</time_frame>
    <description>Using the Functional Assessment of Chronic Illnesses Therapy-Fatigue, score range from 0 to 52, higher scores indicating greater level of energy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Function - Lower Extremity Activities of Daily Living. at 60 Days</measure>
    <time_frame>60 Days</time_frame>
    <description>Scale range 0 to 11, higher scores indicate greater dependency</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Function - Instrumental Activities of Daily Living, at 60 Days</measure>
    <time_frame>60 Days</time_frame>
    <description>Scale range 0 to 11, higher scores indicate greater dependency</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Function - Fatigue/Energy, at 60 Days</measure>
    <time_frame>60 Days</time_frame>
    <description>Scale ranging from 0 to 52, higher scores indicating greater level of energy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Stay in Hospital for United States Participants</measure>
    <time_frame>Days from randomization to discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Stay in Hospital for Canadian Participants</measure>
    <time_frame>Days from randomization to discharge</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">2016</enrollment>
  <condition>Anemia</condition>
  <condition>Hematologic Diseases</condition>
  <condition>Cardiovascular Diseases</condition>
  <condition>Heart Diseases</condition>
  <condition>Myocardial Infarction</condition>
  <condition>Thromboembolism</condition>
  <condition>Pneumonia</condition>
  <condition>Cerebrovascular Accident</condition>
  <arm_group>
    <arm_group_label>Liberal (10 g/dL) Transfusion Strategy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Transfusion strategy that maintains postoperative Hgb levels above 10 g/dL.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Symptomatic transfusion strategy, a more conservative strategy, in which blood transfusion is withheld until the patient develops symptoms of anemia.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Liberal (10 g/dL) Transfusion Strategy</intervention_name>
    <description>This transfusion strategy will maintains postoperative Hgb levels above 10 g/dL. This threshold strategy will use enough red blood cell units to maintain Hgb levels at or above 10 g/dL through hospital discharge or up to 30 days after randomization.</description>
    <arm_group_label>Liberal (10 g/dL) Transfusion Strategy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Restrictive (Symptomatic) Transfusion Strategy</intervention_name>
    <description>Transfusion is withheld until the patient develops symptoms from anemia (i.e., chest pain or ECG changes thought to be ischemic, congestive heart failure, unexplained tachycardia or hypotension unresponsive to fluids) or until the hemoglobin level falls below 8 g/dL. Transfusion is permitted, but is not mandatory, if the hemoglobin level falls below 8 g/dL.</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Has undergone surgical repair for a hip fracture&#xD;
&#xD;
          -  Has a postoperative Hgb level below 10 g/dL within three days of surgery&#xD;
&#xD;
          -  Diagnosis of cardiovascular disease (e.g., coronary artery disease, congestive heart&#xD;
             failure, stroke or transient ischemic attack, or peripheral vascular disease) or&#xD;
             cardiovascular risk factors (e.g., diabetes mellitus, hypertension,&#xD;
             hypercholesterolemia, tobacco use, or creatinine levels greater than 2.0 mg/dL)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unable to walk prior to hip fracture&#xD;
&#xD;
          -  Declines blood transfusions&#xD;
&#xD;
          -  Suffered multiple traumas&#xD;
&#xD;
          -  Pathologic fracture of the hip due to malignancy&#xD;
&#xD;
          -  Clinically recognized acute myocardial infarction within the 30 days prior to study&#xD;
             entry&#xD;
&#xD;
          -  Previously participated in the trial and fractured the other hip&#xD;
&#xD;
          -  Symptoms associated with anemia (e.g., ischemic chest pain) or actively bleeding at&#xD;
             the time of randomization&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeffrey L. Carson, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University Medicine &amp; Dentistry of NJ</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael Terrin</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Maryland, College Park</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Medicine &amp; Dentistry of NJ</name>
      <address>
        <city>New Brunswick</city>
        <state>New Jersey</state>
        <zip>08903</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Carson JL, Terrin ML, Magaziner J, Chaitman BR, Apple FS, Heck DA, Sanders D; FOCUS Investigators. Transfusion trigger trial for functional outcomes in cardiovascular patients undergoing surgical hip fracture repair (FOCUS). Transfusion. 2006 Dec;46(12):2192-206. Review.</citation>
    <PMID>17176334</PMID>
  </reference>
  <results_reference>
    <citation>Carson JL, Terrin ML, Noveck H, Sanders DW, Chaitman BR, Rhoads GG, Nemo G, Dragert K, Beaupre L, Hildebrand K, Macaulay W, Lewis C, Cook DR, Dobbin G, Zakriya KJ, Apple FS, Horney RA, Magaziner J; FOCUS Investigators. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med. 2011 Dec 29;365(26):2453-62. doi: 10.1056/NEJMoa1012452. Epub 2011 Dec 14.</citation>
    <PMID>22168590</PMID>
  </results_reference>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 9, 2003</study_first_submitted>
  <study_first_submitted_qc>October 10, 2003</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 13, 2003</study_first_posted>
  <results_first_submitted>August 14, 2014</results_first_submitted>
  <results_first_submitted_qc>August 14, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">August 28, 2014</results_first_posted>
  <last_update_submitted>October 28, 2020</last_update_submitted>
  <last_update_submitted_qc>October 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rutgers, The State University of New Jersey</investigator_affiliation>
    <investigator_full_name>Jeffrey L Carson, MD</investigator_full_name>
    <investigator_title>Jeffrey L Carson</investigator_title>
  </responsible_party>
  <keyword>Blood Disease</keyword>
  <keyword>blood transfusion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Thromboembolism</mesh_term>
    <mesh_term>Hematologic Diseases</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Liberal (10 g/dL) Transfusion Strategy</title>
          <description>Transfusion strategy that maintains postoperative Hgb levels &gt;= 10 g/dL</description>
        </group>
        <group group_id="P2">
          <title>Restrictive Strategy</title>
          <description>Blood transfusion is withheld until the patient develops symptoms of anemia or at physician discretion of the hemoglobin level falls below 8 g/dL</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1007"/>
                <participants group_id="P2" count="1009"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="998"/>
                <participants group_id="P2" count="1001"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Missing Primary Outcome</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Randomized subjects</population>
      <group_list>
        <group group_id="B1">
          <title>Liberal (10 g/dL) Transfusion Strategy</title>
          <description>Transfusion strategy that maintains postoperative Hgb levels above 10 g/dL.&#xD;
Liberal (10 g/dL) Transfusion Strategy: Maintains postoperative Hgb levels above 10 g/dL. This threshold strategy uses enough red blood cell units to maintain Hgb levels at or above 10 g/dL through hospital discharge or up to 30 days after randomization.</description>
        </group>
        <group group_id="B2">
          <title>Restrictive Strategy</title>
          <description>Symptomatic transfusion strategy, a more conservative strategy, in which blood transfusion is withheld until the patient develops symptoms of anemia.&#xD;
Restrictive (Symptomatic) Transfusion Strategy: Transfusion is withheld until the patient develops symptoms from anemia (i.e., chest pain or ECG changes thought to be ischemic, congestive heart failure, unexplained tachycardia or hypotension unresponsive to fluids) or until the hemoglobin level falls below 8 g/dL. Transfusion is permitted, but is not mandatory, if the hemoglobin level falls below 8 g/dL.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="1007"/>
            <count group_id="B2" value="1009"/>
            <count group_id="B3" value="2016"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="81.8" spread="8.8"/>
                    <measurement group_id="B2" value="81.5" spread="9.0"/>
                    <measurement group_id="B3" value="81.6" spread="8.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="757"/>
                    <measurement group_id="B2" value="770"/>
                    <measurement group_id="B3" value="1527"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="250"/>
                    <measurement group_id="B2" value="239"/>
                    <measurement group_id="B3" value="489"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="609"/>
                    <measurement group_id="B2" value="613"/>
                    <measurement group_id="B3" value="1222"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Canada</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="398"/>
                    <measurement group_id="B2" value="396"/>
                    <measurement group_id="B3" value="794"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Cardiovascular Disease</title>
          <description>History of coronary artery disease, congestive heart failure, cardiovascular disease, or peripheral vascular disease</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>History of Cardiovascular Disease</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="637"/>
                    <measurement group_id="B2" value="631"/>
                    <measurement group_id="B3" value="1268"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No History of Cardiovascular Disease</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="370"/>
                    <measurement group_id="B2" value="378"/>
                    <measurement group_id="B3" value="748"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Inability to Walk 10 Feet or Across a Room Without Human Assistance or Death</title>
        <description>ascertained via telephone follow-up</description>
        <time_frame>60 days after randomization</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Liberal (10 g/dL) Transfusion Strategy</title>
            <description>Transfusion strategy that maintains postoperative Hgb levels &gt;= 10 g/dL</description>
          </group>
          <group group_id="O2">
            <title>Restrictive Strategy</title>
            <description>Blood transfusion is withheld until the patient develops symptoms of anemia or at physician discretion of the hemoglobin level falls below 8 g/dL</description>
          </group>
        </group_list>
        <measure>
          <title>Inability to Walk 10 Feet or Across a Room Without Human Assistance or Death</title>
          <description>ascertained via telephone follow-up</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="998"/>
                <count group_id="O2" value="1001"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="351"/>
                    <measurement group_id="O2" value="347"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other (legacy)</non_inferiority_type>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1.01</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.84</ci_lower_limit>
            <ci_upper_limit>1.22</ci_upper_limit>
            <estimate_desc>Liberal Arm (numerator) compared to Restrictive Arm (denominator)</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Myocardial Infarction, Unstable Angina, or Death for Any Reason</title>
        <time_frame>In-hospital</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Liberal (10 g/dL) Transfusion Strategy</title>
            <description>Transfusion strategy that maintains postoperative Hgb levels &gt;= 10 g/dL</description>
          </group>
          <group group_id="O2">
            <title>Restrictive Strategy</title>
            <description>Symptomatic transfusion strategy, in which blood transfusion is withheld until the patient develops symptoms of anemia or at physician discretion of the hemoglobin level falls below 8 g/dL</description>
          </group>
        </group_list>
        <measure>
          <title>Myocardial Infarction, Unstable Angina, or Death for Any Reason</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1005"/>
                <count group_id="O2" value="1008"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43"/>
                    <measurement group_id="O2" value="52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other (legacy)</non_inferiority_type>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>-0.9</param_value>
            <ci_percent>99</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-3.3</ci_lower_limit>
            <ci_upper_limit>1.6</ci_upper_limit>
            <estimate_desc>Liberal Arm (numerator) compared to Restrictive Arm (denominator)</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mortality at 30 Days</title>
        <time_frame>30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Liberal (10 g/dL) Transfusion Strategy</title>
            <description>Transfusion strategy that maintains postoperative Hgb levels &gt;= 10 g/dL</description>
          </group>
          <group group_id="O2">
            <title>Restrictive Strategy</title>
            <description>Symptomatic transfusion strategy, in which blood transfusion is withheld until the patient develops symptoms of anemia or at physician discretion of the hemoglobin level falls below 8 g/dL</description>
          </group>
        </group_list>
        <measure>
          <title>Mortality at 30 Days</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="995"/>
                <count group_id="O2" value="1000"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52"/>
                    <measurement group_id="O2" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mortality at 60 Days</title>
        <time_frame>60 Days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Liberal (10 g/dL) Transfusion Strategy</title>
            <description>Transfusion strategy that maintains postoperative Hgb levels &gt;= 10 g/dL</description>
          </group>
          <group group_id="O2">
            <title>Restrictive Strategy</title>
            <description>Symptomatic transfusion strategy, in which blood transfusion is withheld until the patient develops symptoms of anemia or at physician discretion of the hemoglobin level falls below 8 g/dL</description>
          </group>
        </group_list>
        <measure>
          <title>Mortality at 60 Days</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="998"/>
                <count group_id="O2" value="1001"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76"/>
                    <measurement group_id="O2" value="66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Composite Outcomes (a) Death, Myocardial Infarction, or Pneumonia and b) Death, Myocardial Infarction, Pneumonia, Thromboembolism, or Stroke</title>
        <time_frame>In-hospital</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Liberal (10 g/dL) Transfusion Strategy</title>
            <description>Transfusion strategy that maintains postoperative Hgb levels &gt;= 10 g/dL</description>
          </group>
          <group group_id="O2">
            <title>Restrictive Strategy</title>
            <description>Symptomatic transfusion strategy, in which blood transfusion is withheld until the patient develops symptoms of anemia or at physician discretion of the hemoglobin level falls below 8 g/dL</description>
          </group>
        </group_list>
        <measure>
          <title>Composite Outcomes (a) Death, Myocardial Infarction, or Pneumonia and b) Death, Myocardial Infarction, Pneumonia, Thromboembolism, or Stroke</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1005"/>
                <count group_id="O2" value="1007"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Death, myocardial infarction, or pneumonia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89"/>
                    <measurement group_id="O2" value="90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Death, MI, pnuemonia, thromboembolism or stroke</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="103"/>
                    <measurement group_id="O2" value="94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Myocardial Infarction</title>
        <time_frame>In-hospital</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Liberal (10 g/dL) Transfusion Strategy</title>
            <description>Transfusion strategy that maintains postoperative Hgb levels &gt;= 10 g/dL</description>
          </group>
          <group group_id="O2">
            <title>Restrictive Strategy</title>
            <description>Symptomatic transfusion strategy, in which blood transfusion is withheld until the patient develops symptoms of anemia or at physician discretion of the hemoglobin level falls below 8 g/dL</description>
          </group>
        </group_list>
        <measure>
          <title>Myocardial Infarction</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1005"/>
                <count group_id="O2" value="1008"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                    <measurement group_id="O2" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Postoperative Complications (e.g., Wound Infection, Thromboembolism, Stroke)</title>
        <time_frame>In hospital</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Liberal (10 g/dL) Transfusion Strategy</title>
            <description>Transfusion strategy that maintains postoperative Hgb levels &gt;= 10 g/dL</description>
          </group>
          <group group_id="O2">
            <title>Restrictive Strategy</title>
            <description>Symptomatic transfusion strategy, in which blood transfusion is withheld until the patient develops symptoms of anemia or at physician discretion of the hemoglobin level falls below 8 g/dL</description>
          </group>
        </group_list>
        <measure>
          <title>Postoperative Complications (e.g., Wound Infection, Thromboembolism, Stroke)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1005"/>
                <count group_id="O2" value="1007"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Wound Infection</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Thromboembolism</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Stroke</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Disposition Status (i.e., Nursing Home Placement)</title>
        <description>Nursing Home Residence</description>
        <time_frame>60 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Liberal (10 g/dL) Transfusion Strategy</title>
            <description>Transfusion strategy that maintains postoperative Hgb levels &gt;= 10 g/dL</description>
          </group>
          <group group_id="O2">
            <title>Restrictive Strategy</title>
            <description>Symptomatic transfusion strategy, in which blood transfusion is withheld until the patient develops symptoms of anemia or at physician discretion of the hemoglobin level falls below 8 g/dL</description>
          </group>
        </group_list>
        <measure>
          <title>Disposition Status (i.e., Nursing Home Placement)</title>
          <description>Nursing Home Residence</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="996"/>
                <count group_id="O2" value="1001"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="137"/>
                    <measurement group_id="O2" value="161"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Function - Lower Extremity Activities of Daily Living,at 30 Days</title>
        <description>Using the Functional Status Index, score range 0 to 11, higher scores indicate greater dependency</description>
        <time_frame>30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Liberal (10 g/dL) Transfusion Strategy</title>
            <description>Transfusion strategy that maintains postoperative Hgb levels &gt;= 10 g/dL</description>
          </group>
          <group group_id="O2">
            <title>Restrictive Strategy</title>
            <description>Symptomatic transfusion strategy, in which blood transfusion is withheld until the patient develops symptoms of anemia or at physician discretion of the hemoglobin level falls below 8 g/dL</description>
          </group>
        </group_list>
        <measure>
          <title>Function - Lower Extremity Activities of Daily Living,at 30 Days</title>
          <description>Using the Functional Status Index, score range 0 to 11, higher scores indicate greater dependency</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="472"/>
                <count group_id="O2" value="507"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.3" spread="4.0"/>
                    <measurement group_id="O2" value="7.4" spread="5.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Function - Instrumental Activities of Daily Living, at 30 Days</title>
        <description>Using the Older Americans Resources and Services Functional Assessment Questionnaire, score range from 0 to 4, higher scores indicating greater dependency</description>
        <time_frame>30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Liberal (10 g/dL) Transfusion Strategy</title>
            <description>Transfusion strategy that maintains postoperative Hgb levels &gt;= 10 g/dL</description>
          </group>
          <group group_id="O2">
            <title>Restrictive Strategy</title>
            <description>Symptomatic transfusion strategy, in which blood transfusion is withheld until the patient develops symptoms of anemia or at physician discretion of the hemoglobin level falls below 8 g/dL</description>
          </group>
        </group_list>
        <measure>
          <title>Function - Instrumental Activities of Daily Living, at 30 Days</title>
          <description>Using the Older Americans Resources and Services Functional Assessment Questionnaire, score range from 0 to 4, higher scores indicating greater dependency</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="437"/>
                <count group_id="O2" value="450"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.9" spread="0.5"/>
                    <measurement group_id="O2" value="3.9" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Function - Fatigue/Energy, at 30 Days</title>
        <description>Using the Functional Assessment of Chronic Illnesses Therapy-Fatigue, score range from 0 to 52, higher scores indicating greater level of energy</description>
        <time_frame>30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Liberal (10 g/dL) Transfusion Strategy</title>
            <description>Transfusion strategy that maintains postoperative Hgb levels &gt;= 10 g/dL</description>
          </group>
          <group group_id="O2">
            <title>Restrictive Strategy</title>
            <description>Symptomatic transfusion strategy, in which blood transfusion is withheld until the patient develops symptoms of anemia or at physician discretion of the hemoglobin level falls below 8 g/dL</description>
          </group>
        </group_list>
        <measure>
          <title>Function - Fatigue/Energy, at 30 Days</title>
          <description>Using the Functional Assessment of Chronic Illnesses Therapy-Fatigue, score range from 0 to 52, higher scores indicating greater level of energy</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="456"/>
                <count group_id="O2" value="459"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.7" spread="7.7"/>
                    <measurement group_id="O2" value="38.6" spread="7.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Function - Lower Extremity Activities of Daily Living. at 60 Days</title>
        <description>Scale range 0 to 11, higher scores indicate greater dependency</description>
        <time_frame>60 Days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Liberal (10 g/dL) Transfusion Strategy</title>
            <description>Transfusion strategy that maintains postoperative Hgb levels &gt;= 10 g/dL</description>
          </group>
          <group group_id="O2">
            <title>Restrictive Strategy</title>
            <description>Symptomatic transfusion strategy, in which blood transfusion is withheld until the patient develops symptoms of anemia or at physician discretion of the hemoglobin level falls below 8 g/dL</description>
          </group>
        </group_list>
        <measure>
          <title>Function - Lower Extremity Activities of Daily Living. at 60 Days</title>
          <description>Scale range 0 to 11, higher scores indicate greater dependency</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="523"/>
                <count group_id="O2" value="553"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.1" spread="4.2"/>
                    <measurement group_id="O2" value="5.1" spread="4.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Function - Instrumental Activities of Daily Living, at 60 Days</title>
        <description>Scale range 0 to 11, higher scores indicate greater dependency</description>
        <time_frame>60 Days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Liberal (10 g/dL) Transfusion Strategy</title>
            <description>Transfusion strategy that maintains postoperative Hgb levels &gt;= 10 g/dL</description>
          </group>
          <group group_id="O2">
            <title>Restrictive Strategy</title>
            <description>Symptomatic transfusion strategy, in which blood transfusion is withheld until the patient develops symptoms of anemia or at physician discretion of the hemoglobin level falls below 8 g/dL</description>
          </group>
        </group_list>
        <measure>
          <title>Function - Instrumental Activities of Daily Living, at 60 Days</title>
          <description>Scale range 0 to 11, higher scores indicate greater dependency</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="389"/>
                <count group_id="O2" value="411"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.7" spread="0.8"/>
                    <measurement group_id="O2" value="3.7" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Function - Fatigue/Energy, at 60 Days</title>
        <description>Scale ranging from 0 to 52, higher scores indicating greater level of energy</description>
        <time_frame>60 Days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Liberal (10 g/dL) Transfusion Strategy</title>
            <description>Transfusion strategy that maintains postoperative Hgb levels &gt;= 10 g/dL</description>
          </group>
          <group group_id="O2">
            <title>Restrictive Strategy</title>
            <description>Symptomatic transfusion strategy, in which blood transfusion is withheld until the patient develops symptoms of anemia or at physician discretion of the hemoglobin level falls below 8 g/dL</description>
          </group>
        </group_list>
        <measure>
          <title>Function - Fatigue/Energy, at 60 Days</title>
          <description>Scale ranging from 0 to 52, higher scores indicating greater level of energy</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="544"/>
                <count group_id="O2" value="525"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41.8" spread="7.3"/>
                    <measurement group_id="O2" value="42.3" spread="7.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of Stay in Hospital for United States Participants</title>
        <time_frame>Days from randomization to discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Liberal (10 g/dL) Transfusion Strategy</title>
            <description>Transfusion strategy that maintains postoperative Hgb levels &gt;= 10 g/dL</description>
          </group>
          <group group_id="O2">
            <title>Restrictive Strategy</title>
            <description>Symptomatic transfusion strategy, in which blood transfusion is withheld until the patient develops symptoms of anemia or at physician discretion of the hemoglobin level falls below 8 g/dL</description>
          </group>
        </group_list>
        <measure>
          <title>Length of Stay in Hospital for United States Participants</title>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="608"/>
                <count group_id="O2" value="612"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.67" spread="3.38"/>
                    <measurement group_id="O2" value="3.97" spread="3.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of Stay in Hospital for Canadian Participants</title>
        <time_frame>Days from randomization to discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Liberal (10 g/dL) Transfusion Strategy</title>
            <description>Transfusion strategy that maintains postoperative Hgb levels &gt;= 10 g/dL</description>
          </group>
          <group group_id="O2">
            <title>Restrictive Strategy</title>
            <description>Symptomatic transfusion strategy, in which blood transfusion is withheld until the patient develops symptoms of anemia or at physician discretion of the hemoglobin level falls below 8 g/dL</description>
          </group>
        </group_list>
        <measure>
          <title>Length of Stay in Hospital for Canadian Participants</title>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="397"/>
                <count group_id="O2" value="394"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.03" spread="9.31"/>
                    <measurement group_id="O2" value="12.70" spread="9.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Up to 60 days following randomization</time_frame>
      <desc>Medical events were captured during hospitalization (up to 30 days); mortality was determined at 60 days. There were a total of 2016 Number of Participants at Risk (1007 in the &quot;Liberal Strategy&quot; and 1009 in the &quot;Restrictive Strategy&quot; Arms/Groups), however, the number at risk was not the same for all events due to some missing data.</desc>
      <group_list>
        <group group_id="E1">
          <title>Liberal (10 g/dL) Transfusion Strategy</title>
          <description>Transfusion strategy that maintains post randomization Hgb levels &gt;= 10 g/dL</description>
        </group>
        <group group_id="E2">
          <title>Restrictive Strategy</title>
          <description>Symptomatic transfusion strategy, in which blood transfusion is withheld until the patient develops symptoms of anemia or at physician discretion of the hemoglobin level falls below 8 g/dL</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="76" subjects_at_risk="1007"/>
                <counts group_id="E2" subjects_affected="66" subjects_at_risk="1009"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Myocardial Infarction</sub_title>
                <description>during hospitalization (up to 30 days)</description>
                <counts group_id="E1" events="23" subjects_affected="23" subjects_at_risk="1005"/>
                <counts group_id="E2" subjects_affected="38" subjects_at_risk="1008"/>
              </event>
              <event>
                <sub_title>Unstable Angina</sub_title>
                <description>during hospitalization (up to 30 days)</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1005"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1008"/>
              </event>
              <event>
                <sub_title>Congestive Heart Failure</sub_title>
                <description>during hospitalization (up to 30 days)</description>
                <counts group_id="E1" events="27" subjects_affected="27" subjects_at_risk="1005"/>
                <counts group_id="E2" events="35" subjects_affected="35" subjects_at_risk="1007"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Death at 60 days</sub_title>
                <description>Detected via telephone follow-up</description>
                <counts group_id="E1" events="76" subjects_affected="76" subjects_at_risk="998"/>
                <counts group_id="E2" events="66" subjects_affected="66" subjects_at_risk="1001"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Stroke</sub_title>
                <description>during hospitalization (up to 30 days)</description>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="1005"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1007"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1007"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1009"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Jeffrey L Carson, MD</name_or_title>
      <organization>Rutgers Robert Wood Johnsom Medical School</organization>
      <phone>732-235-7122</phone>
      <email>Jeffrey.Carson@rutgers.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

